ALSMA Stock Overview
Provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 5/6 |
Past Performance | 1/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
S.M.A.I.O S.A. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €4.32 |
52 Week High | €4.34 |
52 Week Low | €2.14 |
Beta | 0.52 |
11 Month Change | 16.76% |
3 Month Change | 35.85% |
1 Year Change | 71.43% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -22.44% |
Recent News & Updates
Shareholder Returns
ALSMA | FR Medical Equipment | FR Market | |
---|---|---|---|
7D | 1.2% | 7.1% | 0.04% |
1Y | 71.4% | 12.8% | -3.6% |
Return vs Industry: ALSMA exceeded the French Medical Equipment industry which returned 7% over the past year.
Return vs Market: ALSMA exceeded the French Market which returned -4.7% over the past year.
Price Volatility
ALSMA volatility | |
---|---|
ALSMA Average Weekly Movement | 5.5% |
Medical Equipment Industry Average Movement | 5.5% |
Market Average Movement | 4.8% |
10% most volatile stocks in FR Market | 9.5% |
10% least volatile stocks in FR Market | 2.6% |
Stable Share Price: ALSMA's share price has been volatile over the past 3 months.
Volatility Over Time: ALSMA's weekly volatility (5%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2009 | 36 | Philippe Roussouly | smaio.com |
S.M.A.I.O S.A. provides software, implantable devices, and associated services to treat spinal pathologies requiring surgery. The company was incorporated in 2009 and is based in Saint-Priest, France.
S.M.A.I.O S.A. Fundamentals Summary
ALSMA fundamental statistics | |
---|---|
Market cap | €22.53m |
Earnings (TTM) | €1.06m |
Revenue (TTM) | €8.75m |
21.3x
P/E Ratio2.6x
P/S RatioIs ALSMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALSMA income statement (TTM) | |
---|---|
Revenue | €8.75m |
Cost of Revenue | €3.48m |
Gross Profit | €5.27m |
Other Expenses | €4.21m |
Earnings | €1.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Oct 15, 2024
Earnings per share (EPS) | 0.20 |
Gross Margin | 60.25% |
Net Profit Margin | 12.10% |
Debt/Equity Ratio | 28.3% |
How did ALSMA perform over the long term?
See historical performance and comparison